TET2 c.3635T>A ;(p.L1212*)

Variant ID: 4-106164767-T-A

NM_001127208.2(TET2):c.3635T>A;(p.L1212*)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.

The Lancet. Haematology
,
Publication Date: 2022-11-24

Variant appearance in text: TET2: 3635T>A; L1212*
PubMed Link: 36436542
Variant Present in the following documents:
  • mmc2.xlsx, sheet 1
View BVdb publication page



Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

Nature Communications
Nagata, Yasunobu Y; Makishima, Hideki H; Kerr, Cassandra M CM; Przychodzen, Bartlomiej P BP; Aly, Mai M; Goyal, Abhinav A; Awada, Hassan H; Asad, Mohammad Fahad MF; Kuzmanovic, Teodora T; Suzuki, Hiromichi H; Yoshizato, Tetsuichi T; Yoshida, Kenichi K; Chiba, Kenichi K; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Miyano, Satoru S; Mukherjee, Sudipto S; LaFramboise, Thomas T; Nazha, Aziz A; Sekeres, Mikkael A MA; Radivoyevitch, Tomas T; Haferlach, Torsten T; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP
Publication Date: 2019-11-26

Variant appearance in text: TET2: L1212X
PubMed Link: 31772163
Variant Present in the following documents:
  • 41467_2019_13001_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients.

Oncotarget
Montes, Paola P; Kerick, Martin M; Bernal, Mónica M; Hernández, Francisca F; Jiménez, Pilar P; Garrido, Pilar P; Márquez, Ana A; Jurado, Manuel M; Martin, Javier J; Garrido, Federico F; Ruiz-Cabello, Francisco F
Publication Date: 2018-12-11

Variant appearance in text: TET2: 3635T>A; Leu1212*
PubMed Link: 30651926
Variant Present in the following documents:
  • oncotarget-09-36929-s001.pdf
View BVdb publication page



Copy number alterations detected as clonal hematopoiesis of indeterminate potential.

Blood Advances
Takahashi, Koichi K; Wang, Feng F; Kantarjian, Hagop H; Song, Xingzhi X; Patel, Keyur K; Neelapu, Sattva S; Gumbs, Curtis C; Little, Latasha L; Tippen, Samantha S; Thornton, Rebecca R; DiNardo, Courtney D CD; Ravandi, Farhad F; Bueso-Ramos, Carlos C; Zhang, Jianhua J; Wu, Xifeng X; Garcia-Manero, Guillermo G; Futreal, P Andrew PA
Publication Date: 2017-06-27

Variant appearance in text: TET2: L1212X
PubMed Link: 29296745
Variant Present in the following documents:
  • Main text
View BVdb publication page



Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.

The Lancet. Oncology
Takahashi, Koichi K; Wang, Feng F; Kantarjian, Hagop H; Doss, Denaha D; Khanna, Kanhav K; Thompson, Erika E; Zhao, Li L; Patel, Keyur K; Neelapu, Sattva S; Gumbs, Curtis C; Bueso-Ramos, Carlos C; DiNardo, Courtney D CD; Colla, Simona S; Ravandi, Farhad F; Zhang, Jianhua J; Huang, Xuelin X; Wu, Xifeng X; Samaniego, Felipe F; Garcia-Manero, Guillermo G; Futreal, P Andrew PA
Publication Date: 2017-01

Variant appearance in text: TET2: L1212X
PubMed Link: 27923552
Variant Present in the following documents:
  • Main text
View BVdb publication page



Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.

Oncotarget
Kanagal-Shamanna, Rashmi R; Luthra, Rajyalakshmi R; Yin, Cameron C CC; Patel, Keyur P KP; Takahashi, Koichi K; Lu, Xinyan X; Lee, John J; Zhao, Chong C; Stingo, Francesco F; Zuo, Zhuang Z; Routbort, Mark J MJ; Singh, Rajesh R RR; Fox, Patricia P; Ravandi, Farhad F; Garcia-Manero, Guillermo G; Medeiros, L Jeffrey LJ; Bueso-Ramos, Carlos E CE
Publication Date: 2016-03-22

Variant appearance in text: TET2: L1212*
PubMed Link: 26883102
Variant Present in the following documents:
  • oncotarget-07-14251-s001.pdf
View BVdb publication page